Literature DB >> 29261226

In Vitro Assays for the Functional Characterization of the Dopamine Transporter (DAT).

Shaili Aggarwal1, Ole V Mortensen1.   

Abstract

Detailed in this unit are protocols for studying the in vitro uptake of dopamine (DA) as a means for defining the functional characteristics of dopamine transporters. All assays are performed using commercially available cell lines that transiently express the transporter under investigation. The three main assays provided are: a kinetic assay to calculate the affinity (KM ) and maximal velocity (Vmax ) of radiolabeled DA uptake into cells; concentration-response assays to measure the potencies (IC50 /Ki values) of test compounds as transport inhibitors; and an efflux assay to assess the ability and potency (EC50 ) of a ligand to elicit reverse transport of DA accumulated in the cell. Although the methods are described using DAT and its ligands, the same procedure can be employed for studying serotonin and norepinephrine transporters as well. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  dopamine transporter; monoamine; neurotransmitter; uptake

Mesh:

Substances:

Year:  2017        PMID: 29261226      PMCID: PMC5741089          DOI: 10.1002/cpph.33

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  14 in total

1.  A simple technique for reducing edge effect in cell-based assays.

Authors:  Betina Kerstin Lundholt; Kurt M Scudder; Len Pagliaro
Journal:  J Biomol Screen       Date:  2003-10

Review 2.  Transporter assays as useful in vitro tools in drug discovery and development.

Authors:  Donna A Volpe
Journal:  Expert Opin Drug Discov       Date:  2015-10-29       Impact factor: 6.098

Review 3.  Potentiating SLC transporter activity: Emerging drug discovery opportunities.

Authors:  Marie-Laure Rives; Jonathan A Javitch; Alan D Wickenden
Journal:  Biochem Pharmacol       Date:  2017-02-16       Impact factor: 5.858

Review 4.  In vitro methods to support transporter evaluation in drug discovery and development.

Authors:  K L R Brouwer; D Keppler; K A Hoffmaster; D A J Bow; Y Cheng; Y Lai; J E Palm; B Stieger; R Evers
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

Review 6.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

Review 7.  Regulation of monoamine transporters: Role of transporter phosphorylation.

Authors:  Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

Review 8.  Designing modulators of monoamine transporters using virtual screening techniques.

Authors:  Ole V Mortensen; Sandhya Kortagere
Journal:  Front Pharmacol       Date:  2015-09-29       Impact factor: 5.810

Review 9.  Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT.

Authors:  Heidi Koldsø; Julie Grouleff; Birgit Schiøtt
Journal:  Front Pharmacol       Date:  2015-09-24       Impact factor: 5.810

10.  X-ray structures and mechanism of the human serotonin transporter.

Authors:  Jonathan A Coleman; Evan M Green; Eric Gouaux
Journal:  Nature       Date:  2016-04-06       Impact factor: 49.962

View more
  3 in total

1.  Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.

Authors:  Shaili Aggarwal; Xiaonan Liu; Caitlyn Rice; Paul Menell; Philip J Clark; Nicholas Paparoidamis; You-Cai Xiao; Joseph M Salvino; Andréia C K Fontana; Rodrigo A España; Sandhya Kortagere; Ole V Mortensen
Journal:  ACS Chem Neurosci       Date:  2019-06-24       Impact factor: 4.418

2.  Structural insights into GABA transport inhibition using an engineered neurotransmitter transporter.

Authors:  Deepthi Joseph; Smruti Ranjan Nayak; Aravind Penmatsa
Journal:  EMBO J       Date:  2022-07-07       Impact factor: 14.012

3.  A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.

Authors:  Hubert J Sijben; Julie J E van den Berg; Jeremy D Broekhuis; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.